| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Serine/threonine-protein kinase pim-1 |
|---|
| Ligand | BDBM50260553 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_1694026 |
|---|
| IC50 | 2.0±n/a nM |
|---|
| Citation |  Swellmeen, L; Shahin, R; Al-Hiari, Y; Alamiri, A; Hasan, A; Shaheen, O Structure based drug design of Pim-1 kinase followed by pharmacophore guided synthesis of quinolone-based inhibitors. Bioorg Med Chem25:4855-4875 (2017) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Serine/threonine-protein kinase pim-1 |
|---|
| Name: | Serine/threonine-protein kinase pim-1 |
|---|
| Synonyms: | PIM-1 Kinase | PIM1 | PIM1_HUMAN | Proto-oncogene serine/threonine-protein kinase Pim-1 | Serine/threonine-protein kinase (PIM1) | Serine/threonine-protein kinase PIM | Serine/threonine-protein kinase PIM1 | Serine/threonine-protein kinase pim-1 (PIM1) |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 35681.82 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P11309 |
|---|
| Residue: | 313 |
|---|
| Sequence: | MLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD
NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL
ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG
ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI
PFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA
EIHLHSLSPGPSK
|
|
|
|---|
| BDBM50260553 |
|---|
| n/a |
|---|
| Name | BDBM50260553 |
|---|
| Synonyms: | CHEMBL4087294 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C23H24FN5O |
|---|
| Mol. Mass. | 405.468 |
|---|
| SMILES | CC(C)[C@H](C)COc1cncc(n1)-c1ccc2c(c[nH]c2c1)-c1ccc(N)nc1F |r| |
|---|
| Structure | 
|
|---|
Search and Browse
